22 days ago
VRTX
AnalystsMichael YeeMichael Yee's Stock Forecasts
AnalystsMichael Yee
Analyst Ranking
Top 16%
#807 out of 5191 analysts
Average Return
+10.51%
Win Rate
52%44 out of 85
Risk vs Reward
Poor
Good
Michael Yee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Beam Therapeutics IncBEAM | +300.96% | $23.02 | $92.30 | 2020-03-01 - 2021-03-02 | Strong Buy |
Scholar Rock Holding CorpSRRK | +221.62% | $9.02 | $29.01 | 2023-10-24 - 2024-10-24 | Strong Buy |
Rayzebio IncRYZB | +212.45% | $20.00 | $62.49 | 2023-10-09 - 2024-02-23 | Strong Buy |
Denali Therapeutics IncDNLI | +194.23% | $22.69 | $66.76 | 2020-02-23 - 2021-02-24 | Strong Buy |
Kodiak Sciences IncKOD | +157.54% | $10.15 | $26.14 | 2024-12-08 - 2025-12-08 | Strong Buy |
Michael Yee Analyst Color
Get additional color on Michael Yee's coverage of popular stocks
22 days ago
GILD
a month ago
IMCR
a month ago
IVA
a month ago
ANAB
a month ago
BMY
a month ago
GILD
a month ago
LLY
a year ago
ALXO
a year ago
DNLI
2 years ago
NUVB
2 years ago
ALXO
3 years ago
ALGS
3 years ago
MRNA
3 years ago
BIIB
3 years ago
BIIB
Michael Yee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Abbvie IncABBV | 2 | Hold | $230.00 | -0.65% | Maintains | 12 days ago |
Vertex Pharmaceuticals IncVRTX | 5 | Strong Buy | $545.00 | +10.89% | Maintains | 22 days ago |
Gilead Sciences IncGILD | 4 | Strong Buy | $155.00 | +0.01% | Maintains | 22 days ago |
Amgen IncAMGN | 7 | Strong Buy | $390.00 | +5.64% | Maintains | 22 days ago |
Ventyx Biosciences IncVTYX | 3 | Hold | $14.00 | +0.21% | Downgrades | a month ago |
Arcellx IncACLX | 1 | Strong Buy | $100.00 | +45.99% | Assumes | a month ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $50.00 | +65.18% | Assumes | a month ago |
Denali Therapeutics IncDNLI | 3 | Strong Buy | $25.00 | +33.19% | Assumes | a month ago |
Immunocore Holdings PLCIMCR | 2 | Strong Buy | $55.00 | +70.38% | Assumes | a month ago |
Inventiva SaIVA | 1 | Strong Buy | $12.00 | +94.49% | Assumes | a month ago |
Anaptysbio IncANAB | 1 | Strong Buy | $70.00 | +31.88% | Assumes | a month ago |
Viridian Therapeutics IncVRDN | 1 | Strong Buy | $50.00 | +79.21% | Initiates Coverage On | a month ago |
Scholar Rock Holding CorpSRRK | 3 | Strong Buy | $60.00 | +30.49% | Initiates Coverage On | a month ago |
Schrodinger IncSDGR | 2 | Hold | $18.00 | +57.89% | Initiates Coverage On | a month ago |
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $7.00 | +81.82% | Initiates Coverage On | a month ago |
Oruka Therapeutics IncORKA | 2 | Strong Buy | $50.00 | +55.23% | Initiates Coverage On | a month ago |
Olema Pharmaceuticals IncOLMA | 1 | Strong Buy | $45.00 | +99.20% | Initiates Coverage On | a month ago |
Nuvation Bio IncNUVB | 4 | Hold | $10.00 | +73.31% | Initiates Coverage On | a month ago |
Mbx Biosciences IncMBX | 2 | Strong Buy | $60.00 | +57.52% | Initiates Coverage On | a month ago |
Kodiak Sciences IncKOD | 4 | Strong Buy | $50.00 | +126.55% | Initiates Coverage On | a month ago |
Beam Therapeutics IncBEAM | 3 | Hold | $28.00 | +0.29% | Initiates Coverage On | a month ago |
Allogene Therapeutics IncALLO | 1 | Strong Buy | $8.00 | +344.44% | Initiates Coverage On | a month ago |
Zai Lab LtdZLAB | 1 | Strong Buy | $35.00 | +74.74% | Initiates Coverage On | a month ago |
Aligos Therapeutics IncALGS | 2 | Strong Buy | $20.00 | +189.44% | Initiates Coverage On | a month ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $65.00 | +7.01% | Upgrades | a month ago |
Biogen IncBIIB | 6 | Hold | $185.00 | -5.86% | Assumes | a month ago |
Pfizer IncPFE | 1 | Hold | $25.00 | -9.35% | Assumes | a month ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $1,250.00 | +20.19% | Assumes | a month ago |
Cargo Therapeutics IncCRGX | 4 | Hold | $5.00 | +11.86% | Maintains | 7 months ago |
Blueprint Medicines CorpBPMC | 1 | Strong Buy | $135.00 | +4.28% | Initiates Coverage On | a year ago |
Alx Oncology Holdings IncALXO | 4 | Strong Buy | $3.00 | +35.75% | Upgrades | a year ago |
Moderna IncMRNA | 8 | Hold | $55.00 | N/A | Maintains | a year ago |
Axon Enterprise IncAXON | 3 | Strong Buy | $385.00 | N/A | Initiates Coverage On | 2 years ago |
Immuneering CorpIMRX | 2 | Hold | $3.00 | N/A | Downgrades | 2 years ago |
LianbioLIANY | 2 | Hold | $4.00 | N/A | Downgrades | 2 years ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Hold | $45.00 | N/A | Downgrades | 2 years ago |
Amarin Corp PLCAMRN | 8 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Rayzebio IncRYZB | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Prometheus Biosciences IncRXDX | 1 | Hold | $200.00 | N/A | Downgrades | 3 years ago |
Invivyd IncIVVD | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 4 years ago |
Kyntra Bio IncKYNB | 2 | Hold | $1,125.00 | N/A | Downgrades | 5 years ago |
Esperion Therapeutics IncESPR | 3 | Hold | $30.00 | N/A | Downgrades | 5 years ago |
Prothena Corp Public Ltd CoPRTA | 3 | Strong Buy | $30.00 | N/A | Upgrades | 5 years ago |
Assembly Biosciences IncASMB | 2 | Hold | $120.00 | N/A | Downgrades | 5 years ago |
Inhibrx IncINBX1 | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Urogen Pharma LtdURGN | 2 | Strong Buy | $77.00 | N/A | Assumes | 7 years ago |
Immunomedics IncIMMU | 2 | Strong Buy | $30.00 | N/A | Assumes | 7 years ago |
Odonate Therapeutics IncODTC | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 8 years ago |
Acorda Therapeutics IncACORQ | 2 | Hold | $3,000.00 | N/A | Maintains | 8 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Strong Buy | $18.00 | N/A | Maintains | 8 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Strong Buy | $275.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.